2,5-bis(4-methylphenyl)-1,3,4-oxadiazole;ethane;methane;2-methyl-5-(4-methylphenyl)-1,3,4-oxadiazole;2-methyl-5-[4-[5-(4-methylphenyl)-1,3,4-oxadiazol-2-yl]phenyl]-1,3,4-oxadiazole;phenazine;pyrazine;pyridazine;pyridine;pyrimidine;quinoline;quinoxaline

C151H262N20O4 — CID 158336103

IUPAC2,5-bis(4-methylphenyl)-1,3,4-oxadiazole;ethane;methane;2-methyl-5-(4-methylphenyl)-1,3,4-oxadiazole;2-methyl-5-[4-[5-(4-methylphenyl)-1,3,4-oxadiazol-2-yl]phenyl]-1,3,4-oxadiazole;phenazine;pyrazine;pyridazine;pyridine;pyrimidine;quinoline;quinoxaline
SMILESC.C.C.CC.CC.CC.CC.CC.CC.CC.CC.CC.CC.CC.CC.CC.CC.CC.CC.CC.CC.CC.CC.CC.CC.CC.CC.CC.CC.CC.CC.CC.Cc1ccc(-c2nnc(-c3ccc(-c4nnc(C)o4)cc3)o2)cc1.Cc1ccc(-c2nnc(-c3ccc(C)cc3)o2)cc1.Cc1ccc(-c2nnc(C)o2)cc1.c1ccc2nc3ccccc3nc2c1.c1ccc2ncccc2c1.c1ccc2nccnc2c1.c1ccncc1.c1ccnnc1.c1cnccn1.c1cncnc1
InChIInChI=1S/C18H14N4O2.C16H14N2O.C12H8N2.C10H10N2O.C9H7N.C8H6N2.C5H5N.3C4H4N2.29C2H6.3CH4/c1-11-3-5-13(6-4-11)17-21-22-18(24-17)15-9-7-14(8-10-15)16-20-19-12(2)23-16;1-11-3-7-13(8-4-11)15-17-18-16(19-15)14-9-5-12(2)6-10-14;1-2-6-10-9(5-1)13-11-7-3-4-8-12(11)14-10;1-7-3-5-9(6-4-7)10-12-11-8(2)13-10;1-2-6-9-8(4-1)5-3-7-10-9;1-2-4-8-7(3-1)9-5-6-10-8;1-2-4-6-5-3-1;1-2-6-4-3-5-1;1-2-5-4-6-3-1;1-2-4-6-5-3-1;29*1-2;;;/h3-10H,1-2H3;3-10H,1-2H3;1-8H;3-6H,1-2H3;1-7H;1-6H;1-5H;3*1-4H;29*1-2H3;3*1H4
InChIKeyGQPFIQCGICUXPM-UHFFFAOYSA-N
MW2421.89 g/mol
LogP51.27
Rot. Bonds6

About 2,5-bis(4-methylphenyl)-1,3,4-oxadiazole;ethane;methane;2-methyl-5-(4-methylphenyl)-1,3,4-oxadiazole;2-methyl-5-[4-[5-(4-methylphenyl)-1,3,4-oxadiazol-2-yl]phenyl]-1,3,4-oxadiazole;phenazine;pyrazine;pyridazine;pyridine;pyrimidine;quinoline;quinoxaline

2,5-bis(4-methylphenyl)-1,3,4-oxadiazole;ethane;methane;2-methyl-5-(4-methylphenyl)-1,3,4-oxadiazole;2-methyl-5-[4-[5-(4-methylphenyl)-1,3,4-oxadiazol-2-yl]phenyl]-1,3,4-oxadiazole;phenazine;pyrazine;pyridazine;pyridine;pyrimidine;quinoline;quinoxaline (PubChem CID 158336103) has the molecular formula C151H262N20O4 and a molecular weight of 2421.89 g/mol. Its IUPAC name is 2,5-bis(4-methylphenyl)-1,3,4-oxadiazole;ethane;methane;2-methyl-5-(4-methylphenyl)-1,3,4-oxadiazole;2-methyl-5-[4-[5-(4-methylphenyl)-1,3,4-oxadiazol-2-yl]phenyl]-1,3,4-oxadiazole;phenazine;pyrazine;pyridazine;pyridine;pyrimidine;quinoline;quinoxaline.

Molecular Properties

Compound Name2,5-bis(4-methylphenyl)-1,3,4-oxadiazole;ethane;methane;2-methyl-5-(4-methylphenyl)-1,3,4-oxadiazole;2-methyl-5-[4-[5-(4-methylphenyl)-1,3,4-oxadiazol-2-yl]phenyl]-1,3,4-oxadiazole;phenazine;pyrazine;pyridazine;pyridine;pyrimidine;quinoline;quinoxaline
PubChem CID158336103
Molecular FormulaC151H262N20O4
Molecular Weight2421.89 g/mol
Exact Mass2420.09
IUPAC Name2,5-bis(4-methylphenyl)-1,3,4-oxadiazole;ethane;methane;2-methyl-5-(4-methylphenyl)-1,3,4-oxadiazole;2-methyl-5-[4-[5-(4-methylphenyl)-1,3,4-oxadiazol-2-yl]phenyl]-1,3,4-oxadiazole;phenazine;pyrazine;pyridazine;pyridine;pyrimidine;quinoline;quinoxaline
SMILESC.C.C.CC.CC.CC.CC.CC.CC.CC.CC.CC.CC.CC.CC.CC.CC.CC.CC.CC.CC.CC.CC.CC.CC.CC.CC.CC.CC.CC.CC.CC.Cc1ccc(-c2nnc(-c3ccc(-c4nnc(C)o4)cc3)o2)cc1.Cc1ccc(-c2nnc(-c3ccc(C)cc3)o2)cc1.Cc1ccc(-c2nnc(C)o2)cc1.c1ccc2nc3ccccc3nc2c1.c1ccc2ncccc2c1.c1ccc2nccnc2c1.c1ccncc1.c1ccnnc1.c1cnccn1.c1cncnc1
InChIInChI=1S/C18H14N4O2.C16H14N2O.C12H8N2.C10H10N2O.C9H7N.C8H6N2.C5H5N.3C4H4N2.29C2H6.3CH4/c1-11-3-5-13(6-4-11)17-21-22-18(24-17)15-9-7-14(8-10-15)16-20-19-12(2)23-16;1-11-3-7-13(8-4-11)15-17-18-16(19-15)14-9-5-12(2)6-10-14;1-2-6-10-9(5-1)13-11-7-3-4-8-12(11)14-10;1-7-3-5-9(6-4-7)10-12-11-8(2)13-10;1-2-6-9-8(4-1)5-3-7-10-9;1-2-4-8-7(3-1)9-5-6-10-8;1-2-4-6-5-3-1;1-2-6-4-3-5-1;1-2-5-4-6-3-1;1-2-4-6-5-3-1;29*1-2;;;/h3-10H,1-2H3;3-10H,1-2H3;1-8H;3-6H,1-2H3;1-7H;1-6H;1-5H;3*1-4H;29*1-2H3;3*1H4
InChIKeyGQPFIQCGICUXPM-UHFFFAOYSA-N
XLogP51.27
TPSA310.36 Ų
H-Bond Donors
H-Bond Acceptors24
Rotatable Bonds6
Heavy Atoms175
Complexity

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 5002421.89
LogP ≤ 551.27
H-Bond Donors ≤ 50
H-Bond Acceptors ≤ 1024

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'Polycyclic_aromatic_hydrocarbon_2', 'substructure': 'N/A'}

Analyze 2,5-bis(4-methylphenyl)-1,3,4-oxadiazole;ethane;methane;2-methyl-5-(4-methylphenyl)-1,3,4-oxadiazole;2-methyl-5-[4-[5-(4-methylphenyl)-1,3,4-oxadiazol-2-yl]phenyl]-1,3,4-oxadiazole;phenazine;pyrazine;pyridazine;pyridine;pyrimidine;quinoline;quinoxaline with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of 2,5-bis(4-methylphenyl)-1,3,4-oxadiazole;ethane;methane;2-methyl-5-(4-methylphenyl)-1,3,4-oxadiazole;2-methyl-5-[4-[5-(4-methylphenyl)-1,3,4-oxadiazol-2-yl]phenyl]-1,3,4-oxadiazole;phenazine;pyrazine;pyridazine;pyridine;pyrimidine;quinoline;quinoxaline?
The IUPAC name of 2,5-bis(4-methylphenyl)-1,3,4-oxadiazole;ethane;methane;2-methyl-5-(4-methylphenyl)-1,3,4-oxadiazole;2-methyl-5-[4-[5-(4-methylphenyl)-1,3,4-oxadiazol-2-yl]phenyl]-1,3,4-oxadiazole;phenazine;pyrazine;pyridazine;pyridine;pyrimidine;quinoline;quinoxaline (CID 158336103) is 2,5-bis(4-methylphenyl)-1,3,4-oxadiazole;ethane;methane;2-methyl-5-(4-methylphenyl)-1,3,4-oxadiazole;2-methyl-5-[4-[5-(4-methylphenyl)-1,3,4-oxadiazol-2-yl]phenyl]-1,3,4-oxadiazole;phenazine;pyrazine;pyridazine;pyridine;pyrimidine;quinoline;quinoxaline.
What is the SMILES notation for 2,5-bis(4-methylphenyl)-1,3,4-oxadiazole;ethane;methane;2-methyl-5-(4-methylphenyl)-1,3,4-oxadiazole;2-methyl-5-[4-[5-(4-methylphenyl)-1,3,4-oxadiazol-2-yl]phenyl]-1,3,4-oxadiazole;phenazine;pyrazine;pyridazine;pyridine;pyrimidine;quinoline;quinoxaline?
The canonical SMILES for 2,5-bis(4-methylphenyl)-1,3,4-oxadiazole;ethane;methane;2-methyl-5-(4-methylphenyl)-1,3,4-oxadiazole;2-methyl-5-[4-[5-(4-methylphenyl)-1,3,4-oxadiazol-2-yl]phenyl]-1,3,4-oxadiazole;phenazine;pyrazine;pyridazine;pyridine;pyrimidine;quinoline;quinoxaline is C.C.C.CC.CC.CC.CC.CC.CC.CC.CC.CC.CC.CC.CC.CC.CC.CC.CC.CC.CC.CC.CC.CC.CC.CC.CC.CC.CC.CC.CC.CC.Cc1ccc(-c2nnc(-c3ccc(-c4nnc(C)o4)cc3)o2)cc1.Cc1ccc(-c2nnc(-c3ccc(C)cc3)o2)cc1.Cc1ccc(-c2nnc(C)o2)cc1.c1ccc2nc3ccccc3nc2c1.c1ccc2ncccc2c1.c1ccc2nccnc2c1.c1ccncc1.c1ccnnc1.c1cnccn1.c1cncnc1.
What is the InChIKey of 2,5-bis(4-methylphenyl)-1,3,4-oxadiazole;ethane;methane;2-methyl-5-(4-methylphenyl)-1,3,4-oxadiazole;2-methyl-5-[4-[5-(4-methylphenyl)-1,3,4-oxadiazol-2-yl]phenyl]-1,3,4-oxadiazole;phenazine;pyrazine;pyridazine;pyridine;pyrimidine;quinoline;quinoxaline?
The InChIKey is GQPFIQCGICUXPM-UHFFFAOYSA-N. The full InChI is InChI=1S/C18H14N4O2.C16H14N2O.C12H8N2.C10H10N2O.C9H7N.C8H6N2.C5H5N.3C4H4N2.29C2H6.3CH4/c1-11-3-5-13(6-4-11)17-21-22-18(24-17)15-9-7-14(8-10-15)16-20-19-12(2)23-16;1-11-3-7-13(8-4-11)15-17-18-16(19-15)14-9-5-12(2)6-10-14;1-2-6-10-9(5-1)13-11-7-3-4-8-12(11)14-10;1-7-3-5-9(6-4-7)10-12-11-8(2)13-10;1-2-6-9-8(4-1)5-3-7-10-9;1-2-4-8-7(3-1)9-5-6-10-8;1-2-4-6-5-3-1;1-2-6-4-3-5-1;1-2-5-4-6-3-1;1-2-4-6-5-3-1;29*1-2;;;/h3-10H,1-2H3;3-10H,1-2H3;1-8H;3-6H,1-2H3;1-7H;1-6H;1-5H;3*1-4H;29*1-2H3;3*1H4.
What are the key properties of 2,5-bis(4-methylphenyl)-1,3,4-oxadiazole;ethane;methane;2-methyl-5-(4-methylphenyl)-1,3,4-oxadiazole;2-methyl-5-[4-[5-(4-methylphenyl)-1,3,4-oxadiazol-2-yl]phenyl]-1,3,4-oxadiazole;phenazine;pyrazine;pyridazine;pyridine;pyrimidine;quinoline;quinoxaline?
2,5-bis(4-methylphenyl)-1,3,4-oxadiazole;ethane;methane;2-methyl-5-(4-methylphenyl)-1,3,4-oxadiazole;2-methyl-5-[4-[5-(4-methylphenyl)-1,3,4-oxadiazol-2-yl]phenyl]-1,3,4-oxadiazole;phenazine;pyrazine;pyridazine;pyridine;pyrimidine;quinoline;quinoxaline has a molecular weight of 2421.89 g/mol, XLogP of 51.27, 6 rotatable bonds, 0 hydrogen bond donors, and 24 hydrogen bond acceptors.
Where does this data come from?
All data for 2,5-bis(4-methylphenyl)-1,3,4-oxadiazole;ethane;methane;2-methyl-5-(4-methylphenyl)-1,3,4-oxadiazole;2-methyl-5-[4-[5-(4-methylphenyl)-1,3,4-oxadiazol-2-yl]phenyl]-1,3,4-oxadiazole;phenazine;pyrazine;pyridazine;pyridine;pyrimidine;quinoline;quinoxaline is sourced from PubChem (CID 158336103), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).